News

Highlights

Introducing Our New Company Brand

November 15, 2019

Announcements

Lucence Diagnostics and Tan Tock Seng Hospital Collaborate on Decision Support Tool to Reduce Risks of Liver Cancer Surgery

October 9, 2019

Highlights

Lucence Diagnostics Singapore Lab Receives CLIA Certification

September 27, 2019

Events

Lucence wows crowd with cancer-care impact at A*STAR event

September 10, 2019

Events

PD-L1 IHC profiling and implications on immunotherapy for breast cancer management: 7th Genomics Tumor Board Meeting

September 6, 2019

Highlights

Lucence Diagnostics Awarded College of American Pathologists(CAP) Accreditation for Molecular Testing Services

June 25, 2019

Media Release

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

March 12, 2019

Media Release

National Cancer Centre Singapore and Lucence Diagnostics Announce First Molecular Test that Selects Immunotherapy for Kidney Cancer

February 15, 2019

Media Release

Lucence Diagnostics Opens New Headquarters and Molecular Diagnostics Laboratory in Singapore

January 31, 2019

Media Release

iGenetic Diagnostics and Lucence Diagnostics Partner to Deliver Cancer Blood Tests in India

November 23, 2018

Media Release

Lucence Diagnostics Launches World’s First Molecular Test to Guide Surgical Approach for Breast Fibroepithelial Tumors

October 30, 2018

Media Release

Lucence Diagnostics Launches LiquidHALLMARK® Test in Asia for Detecting Multiple Cancer-Causing Mutations and Viruses

October 24, 2018

Events

Lucence wows crowd with cancer-care impact at A*STAR event

September 10, 2019

Events

PD-L1 IHC profiling and implications on immunotherapy for breast cancer management: 7th Genomics Tumor Board Meeting

September 6, 2019

Events

Lucence Diagnostics at Liquid Biopsy Summit in San Francisco

June 20, 2019

Events

Invited Talk at Genome Institute of Singapore Innovation Seminar

June 12, 2019

Events

Lucence Diagnostics Showcases LiquidHALLMARK™ at ASCO 2019

June 10, 2019

Events

Dr. Min-Han Tan Speaks at Pujiang Innovation Forum 2019

May 29, 2019

Events

Predicting Immunotherapy Outcomes: 6th Genomics Tumor Board Meeting

March 12, 2019

Events

Precision Therapy for Gynaecology Cancers: 5th Genomics Tumor Board Meeting

December 4, 2018

Events

Lucence Diagnostics Presents LiquidHALLMARK® at ESMO Asia 2018 Congress

November 27, 2018

Events

Lucence Diagnostics Presents Largest Genetic Study of Vietnamese Patients with Hereditary Breast and Ovarian Cancer Syndrome

November 2, 2018

Events

Genomics Tumor Board #5: Precision Therapy in Gynaecologic Cancers

October 25, 2018

Events

Dr Min-Han Tan Speaks at Best of ASCO Philippines

October 19, 2018

Lymphoma Subtype Test Costing Under $1k Being Developed

The Straits Times May 18, 2019

Lucence Diagnostics’ Cutting-Edge Lung Cancer Genetic Test Available from Next Month

Hong Kong Economic Journal April 29, 2019

Temasek Unit-Backed Firm Lucence to Tap Hong Kong Cancer Screening Market

South China Morning Post April 26, 2019

Lucence Diagnostics to Launch Genetic Test for Lung Cancer

Ta Kung Pao April 25, 2019

Liquid Biopsy Test Aids in Monitoring and Treatment Selection for 14 Types of Cancers

Sky Post April 25, 2019

Lucence Diagnostics Targets Greater Bay Area and United States

Hong Kong Economic Times April 25, 2019

Liquid Biopsy Test that Detects Mutations in 14 Types of Cancers Aims for Early Cancer Screening

HK01 April 24, 2019

Liquid Biopsy Test for Cancer Monitoring – Painless, Affordable, and Accurate

HK01 April 24, 2019

Genomics, Imaging Data to be Fused in Effort to Treat Liver Cancer

Health Data Management March 18, 2019

Focused on Cancer Diagnostics: From Medical Oncologist to Entrepreneur

Lianhe Zaobao March 14, 2019

Lucence, Stanford Researcher to Develop AI Algorithms for Liver Cancer Treatment

Clinical OMICs March 14, 2019

Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment

Investank.com March 12, 2019